Association of overweight with breast cancer survival

American Journal of Epidemiology

Volumn 163, Issue 2, 2006, Pages 101-107

  Tao, Meng Hua ^a,b   Shu, Xiao Ou ^a,d   Zhi, Xian Ruan ^c   Gao, Yu Tang ^c   Zheng, Wei ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Body mass index; Body weight; Breast neoplasms; Mortality; Survival; Waist hip ratio

Indexed keywords

CANCER; WEIGHT; WOMENS HEALTH;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POPULATION RESEARCH; PREDICTION; PROGNOSIS; SURVIVAL TIME;

ADULT; BODY HEIGHT; BODY MASS INDEX; BREAST NEOPLASMS; CHINA; FEMALE; HUMANS; MIDDLE AGED; OVERWEIGHT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS;

ASIA; CHINA; EURASIA; FAR EAST;

EID: 30344432698     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj017     Document Type: Article

References (42)

1. Feigelson HS, Jonas CR, Teras LR, et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2004;13:220-4.
2. Abe R, Kumagai N, Kimura M, et al. Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 1976;120:351-9.
3. Tartter PI, Papatestas AE, Ioannovich J, et al. Cholesterol and obesity as prognostic factors in breast cancer. Cancer 1981;47:2222-7.
4. Greenberg ER, Vessey MP, McPherson K, et al. Body size and survival in premenopausal breast cancer. Br J Cancer 1985;51:691-7.
5. Hebert JR, Augustine A, Barone J, et al. Weight, height and body mass index in the prognosis of breast cancer: early results of a prospective study. Int J Cancer 1988;42:315-18.
6. Kyogoku S, Hirohata T, Takeshita S, et al. Survival of breast-cancer patients and body size indicators. Int J Cancer 1990;46:824-31.
7. Vatten LJ, Foss OP, Kvinnsland S. Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer 1991;27:641-6.
8. Senie RT, Rosen PP, Rhodes P, et al. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 1992;16:26-32.
9. Tornberg S, Carstensen J. Serum beta-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients. Eur J Cancer 1993;29A:2025-30.
10. Katoh A, Watzlaf VJ, D'Amico F. An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 1994;70:928-33.
11. Jain M, Miller AB. Pre-morbid body size and the prognosis of women with breast cancer. Int J Cancer 1994;59:363-8.
12. Bastarrachea J, Hortobagyi GN, Smith TL, et al. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 1994;120:18-25.
13. den Tonkelaar I, de Waard F, Seidell JC, et al. Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project. Breast Cancer Res Treat 1995;34:129-37.
14. Obermair A, Kurz C, Hanzal E, et al. The influence of obesity on the disease-free survival in primary breast cancer. Anti-cancer Res 1995;15:2265-9.
15. Zhang S, Folsom AR, Sellers TA, et al. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer 1995;76:275-83.
16. Maehle BO, Tretli S. Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients. Breast Cancer Res Treat 1996;41:123-30.
17. Newman SC, Lees AW, Jenkins H. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 1997;26:484-90.
18. Chang S, Alderfer JR, Asmar L, et al. Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 2000;64:157-63.
19. Daling JR, Malone KE, Doody DR, et al. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001;92:720-9.
20. Marret H, Rerrotin F, Bougnoux P, et al. Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer. Breast Cancer Res Treat 2001;66:17-23.
21. Petrelli JM, Calle EE, Rodriguez C, et al. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 2002;13:325-32.
22. Dignam JJ, Wieand K, Johnson KA, et al. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003;95:1467-76.
23. Borugian MJ, Sheps SB, Kim-Sing C, et al. Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 2003;158:963-8.
24. Enger SM, Greif JM, Polikoff J, et al. Body weight correlates with mortality in early-stage breast cancer. Arch Surg 2004;139:954-60.
25. Carmichael AR, Bendall S, Lockerbie L, et al. Does obesity compromise survival in women with breast cancer? Breast 2004;13:93-6.
26. Menon KV, Hodge A, Houghton J, et al. Body mass index, height and cumulative menstrual cycles at the time of diagnosis are not risk factors for poor outcome in breast cancer. Breast 1999;8:328-33.
27. Berclaz G, Li S, Price KN, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004;15:875-84.
28. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 2002;20:3302-16.
29. Kumar NB, Cantor A, Allen K, et al. Android obesity at diagnosis and breast carcinoma survival: evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span, and survival from breast carcinoma. Cancer 2000;88:2751-7.
30. Clegg LX, Li FP, Hankey BF, et al. Cancer survival among US whites and minorities. Arch Intern Med 2002;162:1985-93.
31. Kimura M. Obesity as prognostic factors in breast cancer. Diabetes Res Clin Pract 1990;10(suppl 1):S247-51.
32. Gallagher D. Overweight and obesity BMI cut-offs and their relation to metabolic disorders in Koreans/Asians. Obes Res 2004;12:440-1.
33. Moorman PG, Jones BA, Millikan RC, et al. Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol 2001;153:284-91.
34. Tretli S, Haldorsen T, Ottestad L. The effect of pre-morbid height and weight on the survival of breast cancer patients. Br J Cancer 1990;62:299-303.
35. Schapira DV, Kumar NB, Lyman GH. Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer 1991;67:2215-18.
36. MeTiernan A, Rajan KB, Tworoger SS, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003;21:1961-6.
37. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153-65.
38. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20:42-51.
39. Folsom AR, Kushi LH, Anderson KE, et al. Association of general and abdominal obesity with multiple health outcomes in older women. Arch Intern Med 2000;160:2117-28.
40. Chlebowski RT, Weiner JM, Reynolds R, et al. Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 1986;7:23-30.
41. Goodwin PJ, Panzarella T, Boyd NF. Weight gain in women with localized breast cancer - a descriptive study. Breast Cancer Res Treat 1988;11:59-66.
42. Camoriano JK, Loprinzi CL, Ingle JN, et al. Weight change in women with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990;8:1327-34.